David C Hodgson Royalty Pharma PLC (RPRX) insider trading activity

RPRX Quotes by TradingView

David C Hodgson is Director of Royalty Pharma plc. Currently has a direct ownership of 33,328 shares of RPRX, which is worth approximately $1.13 Million. The most recent transaction as insider was on May 13, 2025, when has been sold 7,614 shares (Class A Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.3K
29.61% 3M change
102.96% 12M change
Total Value Held $1.13 Million

DAVID C HODGSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2025
BUY
Grant, award, or other acquisition
-
7,614 Added 18.6%
33,328 Class A Ordinary Shares
Jun 07 2024
BUY
Grant, award, or other acquisition
-
9,293 Added 26.55%
25,714 Class A Ordinary Shares
Jun 23 2023
BUY
Grant, award, or other acquisition
-
7,747 Added 32.05%
16,421 Class A Ordinary Shares
Jul 08 2022
BUY
Grant, award, or other acquisition
-
2,346 Added 21.29%
8,674 Class A Ordinary Shares
Jun 24 2022
BUY
Grant, award, or other acquisition
-
6,328 Added 50.0%
6,328 Class A Ordinary Shares

Also insider at

TNET
TRINET GROUP, INC. Industrials
Director
ALHC
Alignment Healthcare, Inc. Healthcare
Director
DCH

David C Hodgson

Director
New York, NY

Track Institutional and Insider Activities on RPRX

Follow Royalty Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPRX shares.

Notify only if
Any

Insider Trading

Get notified when an Royalty Pharma PLC insider buys or sells RPRX shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Royalty Pharma plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPRX